Henry Schein Current Ratio 2010-2023 | HSIC

Current and historical current ratio for Henry Schein (HSIC) from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Henry Schein current ratio for the three months ending December 31, 2023 was 1.67.
Henry Schein Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-12-31 $4.49B $2.68B 1.67
2023-09-30 $4.11B $2.09B 1.97
2023-06-30 $3.91B $2.28B 1.72
2023-03-31 $3.95B $2.17B 1.82
2022-12-31 $3.99B $2.22B 1.79
2022-09-30 $3.96B $2.15B 1.84
2022-06-30 $3.79B $2.08B 1.83
2022-03-31 $3.83B $2.14B 1.79
2021-12-31 $3.84B $2.31B 1.67
2021-09-30 $3.91B $2.30B 1.70
2021-06-30 $3.74B $2.09B 1.79
2021-03-31 $3.57B $2.12B 1.68
2020-12-31 $3.79B $2.28B 1.66
2020-09-30 $3.87B $2.60B 1.49
2020-06-30 $3.41B $2.31B 1.48
2020-03-31 $3.62B $2.21B 1.64
2019-12-31 $3.23B $2.04B 1.58
2019-09-30 $3.12B $1.91B 1.63
2019-06-30 $3.11B $1.83B 1.70
2019-03-31 $3.11B $1.88B 1.66
2018-12-31 $4.18B $3.22B 1.30
2018-09-30 $4.19B $3.23B 1.30
2018-06-30 $4.06B $3.15B 1.29
2018-03-31 $4.12B $2.86B 1.44
2017-12-31 $4.09B $2.83B 1.44
2017-09-30 $3.78B $2.44B 1.55
2017-06-30 $3.46B $2.23B 1.55
2017-03-31 $3.39B $2.29B 1.48
2016-12-31 $3.34B $2.32B 1.44
2016-09-30 $3.29B $2.04B 1.61
2016-06-30 $3.28B $1.91B 1.72
2016-03-31 $3.27B $1.99B 1.65
2015-12-31 $3.23B $2.15B 1.51
2015-09-30 $3.12B $1.80B 1.74
2015-06-30 $2.91B $1.64B 1.78
2015-03-31 $2.80B $1.55B 1.81
2014-12-31 $2.91B $1.78B 1.64
2014-09-30 $2.93B $1.71B 1.72
2014-06-30 $2.91B $1.54B 1.89
2014-03-31 $2.88B $1.61B 1.78
2013-12-31 $2.84B $1.55B 1.83
2013-09-30 $2.64B $1.45B 1.82
2013-06-30 $2.57B $1.31B 1.96
2013-03-31 $2.59B $1.24B 2.08
2012-12-31 $2.70B $1.47B 1.84
2012-09-30 $2.51B $1.45B 1.73
2012-06-30 $2.33B $1.28B 1.82
2012-03-31 $2.31B $1.14B 2.03
2011-12-31 $2.27B $1.27B 1.79
2011-09-30 $2.32B $1.20B 1.93
2011-06-30 $2.35B $1.24B 1.90
2011-03-31 $2.26B $1.23B 1.83
2010-12-31 $2.17B $1.17B 1.86
2010-09-30 $2.25B $1.29B 1.75
2010-06-30 $2.21B $1.03B 2.16
2010-03-31 $2.22B $1.01B 2.19
2009-12-31 $2.20B $1.08B 2.05
2009-09-30 $2.08B $1.03B 2.02
2009-06-30 $2.09B $1.06B 1.98
2009-03-31 $1.94B $1.01B 1.92
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.396B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.42
West Pharmaceutical Services (WST) United States $26.255B 47.05
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.255B 44.92
Cooper (COO) United States $17.658B 26.72
Labcorp (LH) United States $16.691B 14.40
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.026B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91
Biolase (BIOL) United States $0.005B 0.00